Avenue Therapeutics, Inc. ATXI
0.50
0.14
38.89%
as of 24 Sep
- Market cap
- $680.0K
- P/E
- 0.0×
Follow ATXI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
2.61 | 2.60 | 1.90 | 1.38 | |
Current Ratio |
2.62 | 2.67 | 1.94 | 1.40 | |
Net Debt/EBITDA |
5.12 | 3.80 | 3.39 | 2.75 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.56) | 1.20 | 0.63 | 0.69 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
0.12 | (0.27) | (0.13) | (0.14) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.12 | (0.27) | (0.13) | (0.14) | |
Cash per Share |
1.16 | 0.91 | 0.73 | 0.59 | |
Shareholders Equity per Share |
0.72 | 0.59 | 0.36 | 0.17 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.72 | 0.59 | 0.36 | 0.17 | |
Free Cash Flow |
0.38 | (0.85) | (0.44) | (0.47) | |
Working Capital |
2.30 | 1.83 | 1.20 | 0.57 | |
Net Current Asset Value |
2.30 | 1.83 | 1.20 | 0.57 | |
EV/EBIT |
— | — | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.18 | 0.95 | 1.27 | 1.37 | |
Average Assets |
3.18 | 2.80 | 3.03 | 3.07 | |
Average Common Equity |
1.98 | 1.84 | 1.77 | 1.70 |
Columns are period end dates